Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 54.80
-1.10 (-1.97%)
At close: Jul 9, 2026
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 6.59 billion as of July 9, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
6.59B
Enterprise Value
8.72B
Revenue
4.77B
Ranking
n/a
PE Ratio
19.64
Stock Price
54.80
Market Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 6.59B, an increase of 17.69%. That is a compound annual growth rate of 1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.59B | -7.59% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 13.57B |
| Foresee Pharmaceuticals | 13.09B |
| Standard Chemical & Pharmaceutical | 11.37B |
| Alar Pharmaceuticals | 7.82B |
| Orient Pharma | 6.07B |
| SCI Pharmtech | 5.44B |
| Panion & Bf Biotech | 5.33B |
| LIWANLI Innovation | 4.94B |